The New Empowerment After eXposure to Trauma (NEXT) Study
Key facts
- Who runs it
- Indiana University
- Where
- Indianapolis, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 106 people, planned
- Started
- 24 Sept 2025
- Expected to end
- 31 Jul 2028
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Narrative Exposure Therapy (NET)
- Record updated
- 18 June 2026
Who can take part
- Age
- 18 years to 50 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- 18 years of age or older
- able to read and speak English
- diagnosis of probable PTSD as determined by the PTSD Checklist for DSM-5 (PCL-5)
- pregnant or postpartum (delivered within 12 weeks) at the time of the eligibility screen Exclusion criteria
- current severe suicide risk as determined by the Columbia Suicide Severity Rating Scale Screener (C-SSRS)
- current psychotic or manic symptoms as determined by the DIAMOND screener and the Mood Disorder Questionnaire for Bipolar Disorder
- cognitive impairment
- concurrent trauma-focused psychotherapy
- medical advice limiting participation in exposure therapy
- current legal actions related to trauma
- does not meet criteria for PTSD
- not pregnant or delivered more than 12 weeks after timing of eligibility screening
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
This trial is currently available in United States.
- Indiana University School of MedicineIndianapolis, United StatesContact: Michelle L. Miller, PhDTaking people
About the trial
What the trial wants to find out
The NEXT Study is a randomized controlled pilot examining the feasibility and acceptability of a revised perinatal PTSD protocol. This study will randomize perinatal participants with PTSD to receive NET (n=45); treatment group) and will be compared to perinatal women randomized to usual care (n=45; comparator group). The overall objective of this project is to determine the most feasible and acceptable protocol for a brief virtual perinatal PTSD intervention.
The 2 groups in the trial
- Treatment GroupTreatment being tested
Participants will complete a brief Narrative Exposure Therapy (NET) intervention. NET is a potent exposure-based intervention that is fully manualized, short-term, and developed for individuals with multiple traumas. NET is effective in as little as four sessions and can be completed virtually. NET involves four parts: 1) psychoeducation on trauma exposure and PTSD, 2) laying the Lifeline (constructing a life events inventory, including meaningful events and trauma exposures), 3) exposure sessions (retelling of a traumatic event while constructing the trauma narrative in the context of the life course), and 4) reading of the full written narrative, written by the study therapist after each exposure.
Treatment: Narrative Exposure Therapy (NET)
- Usual Care GroupNo study treatment, for comparison
This group will receive usual care for physical and mental health concerns during pregnancy and the postpartum period. Participation in the usual care group will consist of symptom monitoring (study staff) and participant's primary care/obstetric care for all other concerns. After enrollment in the study, the research assistant will have a structured 10-15 call/visit with usual care group participants to assess existing psychosocial support/health providers and provide a list of mental health services across IUSM and the state of Indiana/perinatal supports. They will encourage participants to follow-up with their primary care/obstetric care provider/community organizations for more help if needed. All usual care group participants will be offered the NET intervention after study assessments have been collected.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07175025, who can take part
- Record updated
- 18 June 2026